DGKN 2022 in Würzburg, Germany

Cerenion will join Bittium at the Congress of the German Society for Clinical Neurophysiology and Functional Imaging (DGKN) on the 10th - 12th of March 2022. The three-day event will bring together the scientific community and the industry for a full program on the science and the state of the art of the field.
At the congress, Bittium will present the Bittium BrainStatus™ with Cerenion C-Trend®, its next-generation continuous EEG (cEEG) monitoring solution for acute and intensive care. In addition, Dr Jukka Kortelainen, MD, PhD, Senior Research Fellow, University of Oulu and the CEO of Cerenion Oy will give a presentation at the Innovators Symposium titled "BrainStatus and C-Trend for practical brain monitoring in ICU".
For more information please see the Bittium press release at https://www.bittium.com/index.php?id=2974&locate=PRM/2022/4204896 or contact Dr. Jukka Kortelainen.

Find out more

Jukka Kortelainen
MD, PhD (Eng.)
CEO, Co-founder
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Cerenion Oy
Kyllikinportti 2
00240 Helsinki
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2024 Cerenion Oy